Salute e Benessere

Jonathan Milner Issues Statement Responding to ISS Report

Jonathan Milner Issues Statement Responding to ISS ReportUrges shareholders to disregard the ISS report and continue to VoteAGAINSTthe current proposed acquisition of Abcam by Danaher CAMBRIDGE, England, 16 October 2023– Jonathan Milner, the founder and one of the largest shareholders in Abcam plc (“Abcam” or the “Company”) (NYSE: ABCM) with ownership of 6.16% of the Company, has today issued the following statement in response to a 16 October 2023 report from Institutional...
Nasdaq GlobeNewswire
16/10/2023

Viking® Changes the Way We Create

Embroider like never before. The new embroidery unit not only has the industry's largest embroidery area, but the new ergonomic hoop connection makes attaching and removing hoops quick and easy. With the groundbreaking industry's first specialty technique hoop, sewists can embroider specialty techniques like felting or bobbin work and flip the hoop over to seamlessly transition to conventional embroidery. New free-arm embroidery capability gives the sewist more flexibility by effortlessly…
PR Newswire
16/10/2023

Safe Orthopaedics announces its revenues for the 3rd half of 2023

Safe group announces sales of €1.35min Q3 2023 Q3 sales of €1.35M versus €1.4M in 2022Cumulative sales 2023 stable compared with 2022Update on the Group's overall situation Éragny-sur-Oise, Fleurieux sur l'Arbresle, France, on October 6 th, 6h30 pm CET –Safe (FR001400F1V2 – ALSAF),French group specialized in the design, manufacturing and distribution of ready-to-use medical devices for Spine surgeries, especially safe for vertebral...
Nasdaq GlobeNewswire
16/10/2023

Research Antibodies & Reagents Market Worth $16.2 Billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94212793 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94212793 Browse in-depth TOC on "Research Antibodies & Reagents Market"479 - Tables 51 - Figures385 - Pages Research Antibodies & Reagents Market Scope: The antibodies segment is expected to grow at the highest CAGR during the forecast period On the basis of...
PR Newswire
16/10/2023

World Health Organization Presents Global Action Plan for Neurological Disorders…

Strategic Objectives for Global Brain HealthIGAP outlines five strategic objectives aimed at achieving significant global health outcomes: Strategic Objectives for Global Brain HealthIGAP outlines five strategic objectives aimed at achieving significant global health outcomes: The WHO will work with Member States to provide resources and tools to support advocates, policymakers, researchers and health care providers in taking the necessary steps to achieve the plan's global strategic…
PR Newswire
16/10/2023

Jonathan Milner releases presentation to Abcam plc shareholders, outlining…

Jonathan Milner releases presentation to Abcam plc shareholders, outlining reasons to reject Danaher's bid and strategic vision for the CompanyCAMBRIDGE, England, 16 October 2023– Dr. Jonathan Milner, the founder and one of the largest shareholders in Abcam plc (“Abcam” or the “Company”) (NYSE: ABCM) with ownership of 6.16%, today issued a presentation covering the reasons for Abcam shareholders to vote against the $24 per share bid from Danaher Corporation (NYSE: DHR) or its affiliates...
Nasdaq GlobeNewswire
16/10/2023

Quotient Sciences Appoints Thierry Van Nieuwenhove as New CEO

Thierry Van Nieuwenhove joins Quotient with an extensive track record in the pharma/CDMO services industry spanning over 23 years, and with experience in both small molecules and biologics. Thierry Van Nieuwenhovejoins Quotient with an extensive track record in the pharma/CDMO services industry spanning over 23 years, and with experience in both small molecules and biologics. Thierry joins from ABL Inc. where he was the Chief Executive Officer for the last two years. Prior to this, he...
PR Newswire
16/10/2023

Nidlegy™ Phase III PIVOTAL trial meets the study's primary objective…

Intratumoral Nidlegy ™followed by surgery significantly improved the Recurrence-Free Survival compared to surgery alonePIVOTAL (NCT02938299) is the first and so far only Phase III trial demonstrating statistically significant and clinically meaningful benefit of a neoadjuvant therapy in fully resectable locally advanced melanoma patients Nidlegy ™is the first immunocytokine product to show positive data in a Phase III randomized clinical trialThe results will be presented at...
Nasdaq GlobeNewswire
16/10/2023

Novo Nordisk A/S – Share repurchase programme

Bagsværd, Denmark, 16 October 2023– On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 30 billion to be executed during a 12-month period beginning 1 February 2023. Under…
Nasdaq GlobeNewswire
16/10/2023

Amolyt Pharma Announces Data on Prevalence of Bone Disease in Patients with…

Patients from the Canadian National Hypoparathyroidism Registry were prospectively screened for bone disease through DXA scan with results demonstrating significant rates of osteopenia, osteoporosis and associated fragility fractures in postmenopausal females Analysis of translational data from pre-clinical and clinical studies of eneboparatide, a PTHR1 agonist in Phase 3 for the treatment of hypoparathyroidism, supports its ability to maintain calcium homeostasis, normalize urinary...
Nasdaq GlobeNewswire
16/10/2023

Theriva™ Biologics Announces Presentation at ESMO Congress 2023 Featuring…

-Results from investigator-sponsored study in collaboration with the Institut Catala d'Oncologia (ICO) show enhanced patient survival, correlating with VCN-01 induced upregulation of PD(L)-1- -Key Opinion Leader (KOL) webinar featuring expert oncologist RicardMesia M.D., Ph.D., to be held Monday, October 23, 2023 at 8:00 a.m. ET- ROCKVILLE, Md., Oct.16, 2023(GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a clinical-stage company...
Nasdaq GlobeNewswire
16/10/2023

Novo Nordisk to acquire ocedurenone for uncontrolled hypertension from KBP…

Bagsværd, Denmark and Singapore, 16 October 2023– Novo Nordisk A/S and KBP Biosciences PTE., Ltd. today announced that Novo Nordisk has agreed to acquire ocedurenone for uncontrolled hypertension with potential application in cardiovascular and kidney disease from KBP Biosciences for up to 1.3 billion US dollars.Ocedurenone is an orally administered, small molecule, non-steroidal mineralocorticoid receptor antagonist (nsMRA) that is currently being examined in the phase 3 trial...
Nasdaq GlobeNewswire
16/10/2023

EcoFlow unveils industry-changing solar energy solutions for the Middle East at…

EcoFlow WAVE 2 is a powerful, portable AC and heater EcoFlow WAVE 2 is a powerful, portable AC and heater DUBAI,UAE,Oct. 16, 2023/PRNewswire/ -- EcoFlow , a leading eco-friendly energy solutions company, today unveiled three ground-breaking devices for theMiddle Eastregion at GITEX Global, taking place at Dubai World Trade Center. The solutions are EcoFlow RIVER 2 Pro, DELTA 2 and WAVE 2. These devices harness the advantages of EcoFlow's battery technology to deliver...
PR Newswire
16/10/2023

Tiziana Life Sciences Announces Positive Six-Month Clinical Results in Multiple…

Numeric improvements were seen across key multiple sclerosis measures, including the Modified Fatigue Impact Scale, Expanded Disability Status Scale, Timed 25-Foot Walk test, Pyramidal Scores and NeuroQoL™ Fatigue scores.Data was presented at ECTRIMS (39 thCongress of the European Committee for Treatment and Research of Multiple Sclerosis) on October 11, 2023 NEW YORK, Oct.16, 2023(GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq:TLSA ) (“Tiziana” or the “Company”), a...
Nasdaq GlobeNewswire
16/10/2023

Oncolytics Biotech® To Present Two Posters on the Pelareorep-Based GOBLET Study…

SAN DIEGO and CALGARY, AB, Oct. 16, 2023/PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a clinical-stage immunotherapeutics company focused on oncology, today announced the publication of two abstracts for posters to be presented during the upcoming European Society for Medical Oncology (ESMO) Congress 2023, taking place from October 20th to 24th at the IFEMA Madrid Conference Center in Madrid, Spain. SAN DIEGO andCALGARY, AB,Oct. 16, 2023/PRNewswire/ --Oncolytics...
PR Newswire
16/10/2023

Tilray Medical Supports New Clinical Trial to Study Medical Cannabis in…

Tilray Medicalproviding the pharmaceutical-grade medical cannabis for the trial (THC/CBD 1:1) for administration to patients. The trial is funded by theMedical Cannabis Bike TourFoundation charity and is scheduled to commence at University Hospital 12 de Octubre, on September 5, 2023. Denise Faltischek, Tilray's Chief Strategy Officer and Head of International Business, stated, "This groundbreaking trial is more than an opportunity for Tilray to engage in medical research; it's a...
Nasdaq GlobeNewswire
16/10/2023

Chest Drainage System Sales to total US$ 1,795.93 million by 2033 fuelled by…

Book the Sample PDF Summary of the Comprehensive Research Report to learn more: https://www.futuremarketinsights.com/reports/sample/rep-gb-7121 Book the Sample PDF Summary of the Comprehensive Research Report to learn more:https://www.futuremarketinsights.com/reports/sample/rep-gb-7121 Chest Drainage Systems: A Crucial Tool for Managing Cardiovascular Diseases, Pleural Effusion, and Cancer Several factors are expected to drive growth in the chest drainage system market...
PR Newswire
16/10/2023

Pen Needles Market Worth $2.5 Billion | MarketsandMarkets

The increasing healthcare expenditure on diabetes care, and mandates pertaining to safety pen needles are some factors that provide lucrative opportunities for key players in the market. However, reuse and misuse of pen injectors, and factors such as needles anxiety and preference of alternative modes of drug delivery, such as infusion pumps, are expected to restrain the market and pose significant challenges for market players. The increasing healthcare expenditure on diabetes care, and...
PR Newswire
16/10/2023

ICEWAVE to Launch New Products Designed for UK Market

ICEWAVE comes from ICCPP Group who have years of experience in powerful technology, innovation and manufacturing. The rising star brand insists on the philosophy of user-centered and experience-first, advocating self-expression and a lifestyle of individuality with trendy designs. ICEWAVE comes from ICCPP Group who have years of experience in powerful technology, innovation and manufacturing. The rising star brand insists on the philosophy of user-centered and experience-first, advocating...
PR Newswire
16/10/2023

Infinium Global Research Forecasts Robust Growth in Ophthalmic Surgical…

Ophthalmic surgery involves a range of surgical procedures performed by ophthalmologists on the eye and its associated structures. Common eye ailments include cataracts, glaucoma, macular degeneration, strabismus, uveitis, and eye tumors. Various advanced technologies, including femtosecond systems, excimer laser systems, phacoemulsification systems, and YAG laser systems, are employed in ophthalmic surgery. Femtosecond laser technology, in particular, is widely utilized for LASIK procedures to…
PR Newswire
16/10/2023

Global Laboratory Information System Market Poised to Reach USD 3.46 Billion by…

Laboratory Information System (LIS) is a specialized healthcare information system designed to manage and store clinical data related to medical processes and tests conducted in clinical laboratories. These software solutions streamline the ordering of laboratory tests, track these orders, and record the results in a searchable database. LIS has traditionally played a vital role in public health institutions, managing and reporting data concerning infection status, immunology, and patient care…
PR Newswire
16/10/2023

Pharmacovigilance and Drug Safety Software Market to Witness Significant Growth…

Pharmacovigilance, a critical component of drug safety, encompasses various activities such as data collection, detection, assessment, monitoring, and prevention of adverse effects associated with pharmaceutical products. It plays a pivotal role in the life science industry, where strict regulatory compliance is mandatory throughout the drug development, manufacturing, and commercialization process. Efficient and effective pharmacovigilance software solutions are essential to ensure the safety…
PR Newswire
16/10/2023

VIRBAC: MAR Weekly Report_VIRBAC SA_9 to 13 October 2023

Statement of transactions in own shares from October 9, 2023 to October 13, 2023BNP PARIBAS EXANE Aggregated presentation by day and by market Name of issuerIdentification code of issuer (Legal Entity Identifier)Day of transactionIdentification code of financial instrumentAggregated daily volume (in number of shares)Daily weighted average price of...
Nasdaq GlobeNewswire
16/10/2023

Orion publishes Interim Report for January–September 2023 on Thursday 26 October…

ORION CORPORATIONPRESS RELEASE16 October 2023 at 12.15 EEST Orion publishes Interim Report for January–September 2023 on Thursday 26 October 2023 Orion will publish Interim Report for January–September 2023 on Thursday, 26 October 2023 at approximately 12.00 noon EEST. The report and related presentation material will be available on the company's website at www.orion.fi/en/investors after publishing. Webcast and conference call A webcast and a conference call for analysts,...
Nasdaq GlobeNewswire
16/10/2023
Altri  Comunicati